ASHFIELD
ActiveSummary
ASHFIELD has been active since 1994 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.3m and a net result of €409,705. Equity is growing by about 16% per year across the filed financial years. Its solvency ranks better than 56% of 6,105 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Board 1
7 not recently confirmed
Day-to-day management 3
Permanent representatives 2
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- not recently confirmed
- began earlier
| Name | Functions and periods |
|---|---|
| Benjamin RAPP |
|
| Thomas Hubert GOTZMANN |
|
| Pharadigm Management |
|
| Clare Jane Bates |
|
| Julian Hedley Tompkins |
|
| Jan NOTEBOOM |
|
| Mick OLEARY |
|
| Jan Van der Auwera |
|
| ENHANCED HEALTHCARE MANAGEMENT |
|
| Mick O'LEARY |
|
| Julian TOMPKINS |
|
| Nigel MANSFORD |
|
| Christophe REYNTJENS |
|
| KPMG |
|
| Clare BATES |
|
| Graham Millan Mcintosh |
|
| Ernst et Young Reviseurs d'Entreprises |
|
| Oliver Oellers |
|
| Reto FLÜCKIGER |
|
| Michael LONSERT |
|
| Pharadigm Management Spri |
|
| Christian MUTZNER |
|
| Philippe Vandiest |
|
| Hervé JOIE |
|
| Michael SCHOMAKER |
|
| Thomas GOTZMANN |
|
| BALARDES |
|
| Jehan Liénart van Lidthe de Jeude |
|
| VANDIEST EN CO |
|
Owners and capital
Owners
2 ownersChain of control
- Ashfield Healthcare GmbhDE
- ASHFIELD
Highest known parent: Ashfield Healthcare Gmbh (Germany). The sources do not say who stands above it.
Owners 2
- Ashfield Healthcare GmbhDEparentSourceown accounts 202599.91%
- Ashfield Direct GmbhDESourceown accounts 20250.09%
According to the 2025 annual accounts of ASHFIELD and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- VANDIEST & C° (BE 0462.673.865) 7,500 shares
- VESALE PHARMACEUTICA 10,000 shares
- Jehan LIENART van LIDTH de JEUDE 15,000 shares
- Bernard LEVIE 27,500 shares
- Olivier Adrien Claude Marie Ghislain Pierre Comte d'URSEL 12,500 shares
- Cédric André Alix Fernand Corneille Ghislain LIENART van LIDTH de JEUDE 12,500 shares
- Cédric Lino Marie Claude Romuald Comte du MONCEAU de BERGENDAL 12,500 shares
- Cédric Marie Simon Pierre François LEVIE 12,500 shares
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 08-10-2021 Capital stated in the deed · €800,000 · 15,207,533 shares
- 01-08-2012 Capital increase of €500,000 · to €800,000 · 9,504,708 new shares · in cash
- 02-08-2010 Capital increase of €1,900,000 · to €4,735,000 · 1,079,248 new shares · in cash
- 02-08-2010 Capital increase of €5,069,741 · to €9,804,741 · 2,879,740 new shares · in kind
- 02-08-2010 Capital increase of €235,000 · to €10,039,741 · from reserves
- 02-08-2010 Capital reduction of €9,739,741 · to €300,000 · to absorb losses
- 30-06-2010 Capital increase of €1,900,000 · 1,079,248 new shares · in cash
- 30-06-2010 Capital increase of €5,069,741 · 2,879,740 new shares · in kind
Show 4 older capital entries
- 30-06-2010 Capital increase of €235,000 · no new shares · from reserves
- 30-06-2010 Capital reduction of €9,739,741 · to absorb losses
- 10-12-2004 Capital increase of €276,895.83 · to €500,000 · from reserves
- 10-12-2004 Capital increase of €110,000 · to €610,000 · 110,000 new shares